Pergi ke luar talian dengan aplikasi Player FM !
Man who turned blind after taking kala azar medicine regain vision after surgery
Siri yang diarkibkan ("Suapan tidak aktif" status)
When? This feed was archived on June 12, 2025 23:12 (). Last successful fetch was on December 05, 2024 12:11 ()
Why? Suapan tidak aktif status. Pelayan kami tidak dapat untuk mendapatkan kembali suapan podcast yang sah untuk tempoh yang didapati.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 420452803 series 2533765
In April 2024, that is last month, Suno India published the story featuring Iliyas Marandi, a 23-year-old tribal man who lost his eyesight after taking miltefosine drug for Post-Kala-azar Dermal Leishmaniasis, a skin manifestation of the deadly Kala-azar. This May, he underwent a corneal implant surgery at Indira Gandhi Institute of Medical Sciences. Suno India’s Menaka Rao spoke to Iliyas after the surgery, and his doctor, Dr Rakhi Kusumesh. This is Iliyas’s second corneal implant.
In 2022, the World Health Organization stated that 83 cases in India had possible links to miltefosine intake. While the government issued guidelines in 2022 to prevent people from losing vision after taking miltefosine, there are no plans yet for those who lost eyesight before 2022. Iliyas is one such person. He has so far mostly sought medical help with his own money, and resources. Except for some Ayushman Bharat scheme’s insurance money, Iliyas was on his own for this corneal implant too.
See sunoindia.in/privacy-policy for privacy information.
168 episod
Siri yang diarkibkan ("Suapan tidak aktif" status)
When? This feed was archived on June 12, 2025 23:12 (). Last successful fetch was on December 05, 2024 12:11 ()
Why? Suapan tidak aktif status. Pelayan kami tidak dapat untuk mendapatkan kembali suapan podcast yang sah untuk tempoh yang didapati.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 420452803 series 2533765
In April 2024, that is last month, Suno India published the story featuring Iliyas Marandi, a 23-year-old tribal man who lost his eyesight after taking miltefosine drug for Post-Kala-azar Dermal Leishmaniasis, a skin manifestation of the deadly Kala-azar. This May, he underwent a corneal implant surgery at Indira Gandhi Institute of Medical Sciences. Suno India’s Menaka Rao spoke to Iliyas after the surgery, and his doctor, Dr Rakhi Kusumesh. This is Iliyas’s second corneal implant.
In 2022, the World Health Organization stated that 83 cases in India had possible links to miltefosine intake. While the government issued guidelines in 2022 to prevent people from losing vision after taking miltefosine, there are no plans yet for those who lost eyesight before 2022. Iliyas is one such person. He has so far mostly sought medical help with his own money, and resources. Except for some Ayushman Bharat scheme’s insurance money, Iliyas was on his own for this corneal implant too.
See sunoindia.in/privacy-policy for privacy information.
168 episod
Semua episod
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.